{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:36:43Z","timestamp":1790307403552,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030958","name":"ETOP IBCSG Partners Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019322","name":"BioTheranostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.breast.2026.104714","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:01:48Z","timestamp":1769713308000},"page":"104714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identifying premenopausal patients with early-stage hormone receptor\u2013positive breast cancer at minimal risk of distant recurrence by breast cancer index"],"prefix":"10.1016","volume":"86","author":[{"given":"Ruth M.","family":"O'Regan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4642-2147","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2845-4023","authenticated-orcid":false,"given":"Gini F.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-9286","authenticated-orcid":false,"given":"Prudence A.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roswitha","family":"Kammler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9166-0829","authenticated-orcid":false,"given":"Patrizia","family":"Dell\u2019Orto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherene","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5743-3013","authenticated-orcid":false,"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3443-3578","authenticated-orcid":false,"given":"Kai","family":"Treuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2428-6109","authenticated-orcid":false,"given":"Meredith M.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.breast.2026.104714_bib1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1200\/JCO.22.01065","article-title":"Adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from SOFT","volume":"41","author":"Francis","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.breast.2026.104714_bib2","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.22.01064","article-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer: long-term Follow-Up of the combined TEXT and SOFT trials","volume":"41","author":"Pagani","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.breast.2026.104714_bib3","article-title":"Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer","volume":"3","author":"Bui","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.breast.2026.104714_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","article-title":"Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials","volume":"23","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.breast.2026.104714_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.breast.2026.104714_bib7","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1078-0432.CCR-21-3385","article-title":"Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study","volume":"28","author":"Bartlett","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.breast.2026.104714_bib8","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1158\/1078-0432.CCR-23-2436","article-title":"Validation of the prognostic performance of breast cancer index in hormone receptor-positive postmenopausal breast cancer patients in the TEAM trial","volume":"30","author":"Bartlett","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.breast.2026.104714_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1158\/1078-0432.CCR-20-2737","article-title":"Breast Cancer Index predicts extended endocrine benefit to individualize selection of patients with HR(+) early-stage breast cancer for 10 years of endocrine therapy","volume":"27","author":"Noordhoek","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10.1016\/j.breast.2026.104714_bib10","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/jnci\/djt146","article-title":"Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13\/IL17BR biomarker","volume":"105","author":"Sgroi","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.1016\/j.breast.2026.104714_bib11","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1158\/1078-0432.CCR-13-0804","article-title":"Breast Cancer Index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence","volume":"19","author":"Zhang","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.breast.2026.104714_bib12","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1158\/1078-0432.CCR-17-1688","article-title":"A novel Breast Cancer Index for prediction of distant recurrence in HR(+) early-stage breast cancer with one to three positive nodes","volume":"23","author":"Zhang","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.breast.2026.104714_bib13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaoncol.2024.3044","article-title":"Breast cancer index in premenopausal women with early-stage hormone receptor-positive breast cancer","volume":"10","author":"O'Regan","year":"2024","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.breast.2026.104714_bib14","article-title":"Assessment of ovarian function suppression (OFS)-containing adjuvant endocrine therapy in premenopausal women by Breast cancer Index","volume":"8","author":"O'Regan","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.breast.2026.104714_bib15","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/1078-0432.CCR-24-3836","article-title":"Identification of early-stage breast cancer with a minimal risk of recurrence by the breast cancer index","volume":"31","author":"Jilderda","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2026.104714_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-025-00885-x","article-title":"Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer","author":"Jilderda","year":"2025","journal-title":"npj Breast Cancer"},{"issue":"5","key":"10.1016\/j.breast.2026.104714_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1412379","article-title":"Adjuvant ovarian suppression in premenopausal breast cancer","volume":"372","author":"Francis","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.breast.2026.104714_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1404037","article-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer","volume":"371","author":"Pagani","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.breast.2026.104714_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2015.65.9573","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology Clinical Practice Guideline update on ovarian suppression","volume":"34","author":"Burstein","year":"2016","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104714_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.18.01967","article-title":"Absolute improvements in freedom from distant recurrence to tailor adjuvant endocrine therapies for premenopausal women: results from TEXT and SOFT","volume":"38","author":"Pagani","year":"2020","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.breast.2026.104714_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.21.02019","article-title":"Outcome of patients with an ultralow-risk 70-gene signature in the MINDACT trial","volume":"40","author":"Lopes Cardozo","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762600024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762600024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:31:00Z","timestamp":1775683860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762600024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"alternative-id":["S096097762600024X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104714","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying premenopausal patients with early-stage hormone receptor\u2013positive breast cancer at minimal risk of distant recurrence by breast cancer index","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104714"}}